These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 18342502)
1. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Uyttebroeck A; Suciu S; Laureys G; Robert A; Pacquement H; Ferster A; Marguerite G; Mazingue F; Renard M; Lutz P; Rialland X; Mechinaud F; Cavé H; Baila L; Bertrand Y; Eur J Cancer; 2008 Apr; 44(6):840-6. PubMed ID: 18342502 [TBL] [Abstract][Full Text] [Related]
2. Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies. Stark B; Avrahami G; Nirel R; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S Br J Haematol; 2009 Oct; 147(1):113-24. PubMed ID: 19694717 [TBL] [Abstract][Full Text] [Related]
3. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. Burkhardt B; Woessmann W; Zimmermann M; Kontny U; Vormoor J; Doerffel W; Mann G; Henze G; Niggli F; Ludwig WD; Janssen D; Riehm H; Schrappe M; Reiter A J Clin Oncol; 2006 Jan; 24(3):491-9. PubMed ID: 16421426 [TBL] [Abstract][Full Text] [Related]
4. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010. Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G; Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160 [TBL] [Abstract][Full Text] [Related]
10. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737 [TBL] [Abstract][Full Text] [Related]
11. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse. Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932 [TBL] [Abstract][Full Text] [Related]
14. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. Hutchinson RJ; Gaynon PS; Sather H; Bertolone SJ; Cooper HA; Tannous R; Wells LM; Heerema NA; Sailer S; Trigg ME; J Clin Oncol; 2003 May; 21(9):1790-7. PubMed ID: 12721256 [TBL] [Abstract][Full Text] [Related]
15. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study. Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
17. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group. Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol]. Gu LJ; Li J; Xue HL; Tang JY; Chen J; Zhao HJ; Chen J; Ye H; Wang YP; Pan C Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):1-4. PubMed ID: 14990066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]